Co-founder & Chief Architect
Throughout her professional career, Anastasia Zamyshlyaeva has made a notable impact on what’s possible with the power of data in pharma, biotech, medical device, and healthcare industries. Early in her career, she designed and developed new products and features for a multi-domain MDM hub, and took a key role in the design and creation of a metadata-driven framework for configuring and running web-applications for management and consolidation of customer data.
In 2011, Anastasia co-founded Reltio with the mission to solve some of the biggest data and analytics problems that others had not yet been able to address. She architected the solution, Reltio Cloud—from the ground up—which enables business users to gain direct and immediate access to the information they needed to do their jobs better and faster, with the pharmaceutical and healthcare industries being the first focus. Anastasia was also a key player in the creation and delivery of Reltio IQ, an advanced analytics module that provides a foundation of reliable data for analytics and machine learning, solving one of the key challenges in the area—analytics platforms delivering incorrect insights based on poor, outdated data. Additionally, this innovation brings together reliable data, relevant insights, and recommended actions via machine learning into one self-learning data application.
As Co-founder and Chief Architect, Anastasia has played a key role in Reltio’s rising success. In 2017, the company was ranked #153 in the prestigious Inc. 5000 list of America’s fastest-growing private companies, with a three-year revenue growth rate of 2568%—placing it among the top 4% fastest-growing private companies in the nation. Inc.com also ranked Reltio in the country’s top 10 fastest-growing software companies, and the seventh fastest-growing among companies in the San Francisco Bay Area. This was, in part, thanks to Anastasia’s technical innovations in bringing a new Self-Learning Data Platform to organizations around the globe, including 7 of the top 10 global life science companies, delivering data-driven applications that people can use every day to gain insights and actions from their data assets.